MedTrace Logo

Optimization of a Decision Formula for Optimal Timing of Immunosuppressive Therapy Initiation in Primary Membranous Nephropathy: A Multicenter Retrospective Cohort Study

NCT06924476 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 282

Last updated 2025-04-11

No results posted yet for this study

Summary

The goal of this observational study is to optimize the evaluation formula for the timing of initiating immunosuppressive therapy in primary membranous nephropathy in patients with primary membranous nephropathy. The main question it aims to answer is:When should immunosuppressive therapy be initiated?This study is a retrospective one. Participants will not receive any treatment.

Conditions

Sponsors & Collaborators

  • Peking University First Hospital

    collaborator OTHER

  • Yipeng Liu

    lead OTHER

Principal Investigators

  • Yipeng Liu · Qianfoshan Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1990-01-01
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06924476 on ClinicalTrials.gov